Helicobacter pylori infection medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 13: | Line 13: | ||
|- | |- | ||
| | | | ||
*PPI+Clarithromycin+Amoxicillin or metronidazole | * PPI+Clarithromycin+Amoxicillin or metronidazole | ||
(Clarithromycin-based triple therapy) | (Clarithromycin-based triple therapy) | ||
*14 days | * 14 days | ||
or | or | ||
*PPI or H2RA+ Bismuth+Metronidazole+Tetracycline | * PPI or H2RA+ Bismuth+Metronidazole+Tetracycline | ||
(Bismuth quadruple therapy) | (Bismuth quadruple therapy) | ||
*10-14days | * 10-14days | ||
| | | | ||
*PPI+ Amoxicillin | * PPI+ Amoxicillin | ||
*5 days | * 5 days | ||
Followed by | Followed by | ||
*PPI+Clarithromycin+Tinidazole | * PPI+Clarithromycin+Tinidazole | ||
*Additional 5 days | * Additional 5 days | ||
(Alternative to clarithromycin-based triple or bismuth quadruple therapy) | (Alternative to clarithromycin-based triple or bismuth quadruple therapy) | ||
|- | |- | ||
Revision as of 17:15, 17 January 2017
|
Helicobacter pylori infection Microchapters |
|
Differentiating Helicobacter pylori infection from other Diseases |
|---|
|
Diagnosis |
|
Guideline Recommendation |
|
Treatment |
|
Case Studies |
|
Helicobacter pylori infection medical therapy On the Web |
|
American Roentgen Ray Society Images of Helicobacter pylori infection medical therapy |
|
Directions to Hospitals Treating Helicobacter pylori infection |
|
Risk calculators and risk factors for Helicobacter pylori infection medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Medical Therapy
Primary Treatment for H.pylori Infection
| Primary Therapy | Sequential Therapy |
|---|---|
(Clarithromycin-based triple therapy)
or
(Bismuth quadruple therapy)
|
Followed by
(Alternative to clarithromycin-based triple or bismuth quadruple therapy) |
| Recommended treatment in the United States | Requires validation in the United States before it can be recommended as a first line therapy |